IntrinsicIntrinsic
← Scroll for more →

Financial Statements — LMED

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Cash & Equivalents0.000.000.000.000.000.000.000.000.00
Total Current Assets0.000.000.000.000.000.000.000.000.00
Total Non-current Assets*7.827.820.000.000.000.000.000.000.00
Total Assets7.827.820.000.000.000.000.000.000.00
Accounts Payable0.290.260.240.280.250.240.230.240.21
Total Current Liabilities0.770.680.630.660.630.600.570.650.60
Total Non-current Liabilities*0.000.000.000.000.000.000.000.000.00
Total Liabilities0.770.680.630.660.630.600.570.650.60
Retained Earnings(29.74)(29.65)(29.60)(29.48)(29.45)(29.42)(29.39)(28.48)(28.43)
Total Stockholder Equity7.057.14(0.63)(0.66)(0.63)(0.60)(0.57)(0.65)(0.60)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Total Revenue0.000.000.000.000.000.000.000.000.00
Selling, General & Admin0.040.010.140.000.000.000.950.021.51
Total Operating Expenses0.080.040.110.030.020.020.980.031.52
Operating Income(0.08)(0.04)(0.11)(0.03)(0.02)(0.02)(0.98)(0.03)(1.52)
Interest Expense0.010.010.010.010.010.010.010.010.01
Pretax Income(0.09)(0.05)(0.12)(0.04)----------
Tax Provision0.000.000.000.000.000.000.000.000.00
Net Income(0.09)(0.05)(0.12)(0.04)(0.03)(0.02)(0.92)(0.04)(1.53)
Basic EPS0.00----------------
← Scroll for more columns →

Cash Flow Statement

(in thousands USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Operating Cash Flow(55.03)(28.38)(158.09)(13.83)(14.85)(19.01)(9.61)(12.67)(44.55)
Financing Cash Flow55.0328.38158.0913.8314.8519.029.6112.6744.55
← Scroll for more columns →